How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biodegradable Type Embolic Microspheres Market
- By Material Type: Polylactic Acid (PLA) Microspheres, Poly(lactic-co-glycolic acid) (PLGA) Microspheres, Chitosan-based Microspheres, Gelatin-based Microspheres, Alginate Microspheres
- By Particle Size: 100-300 microns, 300-500 microns, 500-700 microns, 700-900 microns, 900-1200 microns
- By Application: Uterine Fibroid Embolization, Liver Cancer Embolization, Peripheral Arterial Embolization, Prostate Artery Embolization, Arteriovenous Malformation Embolization
- By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Interventional Radiology Centers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polylactic Acid (PLA) Microspheres leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Biodegradable Type Embolic Microspheres Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Particle Size 5
Application 5
End User 4
Companies profiled
Boston Scientific Corporation
Terumo Corporation
Biosphere Medical
Merit Medical Systems Inc.
Biocompatibles UK Ltd (a BTG company)
CeloNova Biosciences Inc.
Cook Medical
Beijing Sunmed Medical Devices Co. Ltd.
Stryker Corporation
Medtronic plc
Johnson & Johnson (Cordis)
Penumbra Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Biosphere Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merit Medical Systems Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Biocompatibles UK Ltd (a BTG company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →CeloNova Biosciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Beijing Sunmed Medical Devices Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Johnson & Johnson (Cordis)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Penumbra Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →MicroVention Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Guerbet Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biocompatibles International plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$2,227M by 2033 · 11.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polylactic Acid (PLA) Microspheres55.9
- Poly(lactic-co-glycolic acid) (PLGA) Microspheres6.1
- Chitosan-based Microspheres15.4
- Gelatin-based Microspheres12.2
- Alginate Microspheres10.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$319.0M → $661.7M · 9.5%
Europe$222.4M → $481.7M · 10.1%
Asia Pacific$203.0M → $425.3M · 9.7%
Latin America$125.7M → $317.0M · 12.3%
Middle East and Africa$96.7M → $215.7M · 10.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.952026
10.972027
10.982028
10.992029
10.992030
11.002031
11.032032
11.022033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Boston Scientific Corporation13.1
- Terumo Corporation27.9
- Biosphere Medical7.7
- Merit Medical Systems Inc.6.2
- Biocompatibles UK Ltd (a BTG company)11.5
- CeloNova Biosciences Inc.5.7
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type20.6%
Particle Size16.7%
Application40.2%
End User22.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe22.9
- Asia Pacific20.2
- Latin America15.1
- Middle East and Africa10.3
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 98 | 79 | 95 | 75 | 89 | 99 | 89 |
| Terumo Corporation | 81 | 93 | 92 | 80 | 74 | 86 | 84 |
| Biosphere Medical | 67 | 83 | 65 | 79 | 77 | 63 | 72 |
| Merit Medical Systems Inc. | 57 | 71 | 57 | 65 | 76 | 62 | 65 |
| Biocompatibles UK Ltd (a BTG company) | 58 | 58 | 66 | 56 | 62 | 54 | 59 |
| CeloNova Biosciences Inc. | 46 | 60 | 69 | 48 | 66 | 48 | 56 |
| Cook Medical | 60 | 42 | 55 | 65 | 52 | 64 | 56 |
| Beijing Sunmed Medical Devices Co. Ltd. | 47 | 35 | 39 | 53 | 39 | 54 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Boston Scientific Corporation
- Terumo Corporation
- Biosphere Medical
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Terumo Corporation | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Biosphere Medical | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Merit Medical Systems Inc. | − | ✓ | − | − | ◐ | − |
| Biocompatibles UK Ltd (a BTG company) | ◐ | − | ◐ | − | − | − |
| CeloNova Biosciences Inc. | − | ◐ | ◐ | ◐ | ✓ | − |
| Cook Medical | ◐ | − | ◐ | − | − | ◐ |
| Beijing Sunmed Medical Devices Co. Ltd. | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Boston Scientific Corporation89
2Terumo Corporation84
3Biosphere Medical72
4Merit Medical Systems Inc.65
5Biocompatibles UK Ltd (a BTG company)59
6CeloNova Biosciences Inc.56
7Cook Medical56
8Beijing Sunmed Medical Devices Co. Ltd.45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Boston Scientific CorporationTerumo Corporation
Challenger1
Strong scale, closing on the leaders.
Biosphere Medical
Contender2
Focused players with pockets of strength.
Merit Medical Systems Inc.Biocompatibles UK Ltd (a BTG company)
Niche3
Specialists in a single segment or region.
CeloNova Biosciences Inc.Cook MedicalBeijing Sunmed Medical Devices Co. Ltd.
Go-to-market strategy
Land Material Type in North America, then scale across Biodegradable Type Embolic Microspheres Market — a $207M beachhead inside a $2.90B market.
Beachhead (SOM)$207Mobtainable near-term
Serviceable (SAM)$1.16Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Polylactic Acid (PLA) Microspheres
Best fit — highest urgency & budget in Material Type.
Economic buyer78 fit
Poly(lactic-co-glycolic acid) (PLGA) Microspheres
Strong fit — clear ROI and a fast path to value.
End user64 fit
Chitosan-based Microspheres
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Particle Size & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biodegradable Type Embolic Microspheres Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified20%
Evaluation11%
Closed-won6%
$14.5KCAC
$81KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Investment thesis
Biodegradable Type Embolic Microspheres Market is a durable-growth opportunity — $8.17B by 2033, compounding at 8.7%.
TAM · 2025$4.18Btoday
TAM · 2033$8.17Bforecast
CAGR8.7%2027–2033
Cumulative$53.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.17BTotal addressable market
SAM$3.38BServiceable available market
SOM$647MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.7% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.17BLarge & growingTAM by 2033 at 8.7% CAGR
$3.38BServiceable nowreachable with today’s model
$647MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.37BBear5.7% CAGR
$8.17BBase8.7% CAGR
$10.5BBull11.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Particle Size optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biodegradable Type Embolic Microspheres Market — a $4.16B market by 2033. Plan: grow share from 9.6% to 16.6%.
Market size · 2033$4.16Btotal addressable
Market CAGR7.4%2027–2033
Target share16.6%from 9.6% today
Revenue ambition$690Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.6% | 16.6% | Behind |
| Revenue | $438M | $690M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 28.4% | 38.9% | At risk |
| Customer retention | 90.9% | 95.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Particle Size capability
A defensible second engine — invest in Particle Size to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Particle Size
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $84M capacity & capability investment
- Greenlight bolt-on M&A in Particle Size
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAhead
Sales deck · value proposition
Win the Biodegradable Type Embolic Microspheres Market conversation — a $896M market you can size, segment and defend in minutes.
Market size · 2033$896Mtotal opportunity
Growth4.7%CAGR to 2033
Addressable buyers1,541+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 2 mopayback period
$72K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Boston Scientific CorporationTerumo CorporationBiosphere MedicalMerit Medical Systems Inc.Biocompatibles UK Ltd (a BTG company)CeloNova Biosciences Inc.Cook MedicalBeijing Sunmed Medical Devices Co. Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biodegradable Type Embolic Microspheres Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biodegradable Type Embolic Microspheres Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biodiesel Determinator Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportBiodiesel Purification By Ion Exchange Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportBiodiesel Purification By Ion Exchange Resin Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportBiodigester Tank Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBioDME Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportBioelectrochemical Instruments Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportBio-emulsion Polymers Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportBioethanol as a Biofuel Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportBioethanol Fireplaces Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportBiofeedback Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportBiofeedback System Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportBioflavonoids Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.